Papers
List our Papers
Telomerase and HER-2/neu as targets of genetic cancer vaccines in dogs.
Peruzzi D, Mesiti G, Ciliberto G, La Monica N, Aurisicchio L. Vaccine. 2010 Feb 3;28(5):1201-8. doi: 10.1016/j.vaccine.2009.11.031. Epub 2009 Nov 26.
Engineered adenovirus serotypes for overcoming anti-vector immunity.
Dharmapuri S, Peruzzi D, Aurisicchio L. Expert Opin Biol Ther. 2009 Oct;9(10):1279-87. doi: 10.1517/14712590903187053. Review.
Coadministration of telomerase genetic vaccine and a novel TLR9 agonist in nonhuman primates.
Dharmapuri S, Peruzzi D, Mennuni C, Calvaruso F, Giampaoli S, Barbato G, Kandimalla ER, Agrawal S, Scarselli E, Mesiti G, Ciliberto G, La Monica N, Aurisicchio L. Mol Ther. 2009 Oct;17(10):1804-13. doi: 10.1038/mt.2009.165. Epub 2009 Jul 21.
MMP11: a novel target antigen for cancer immunotherapy.
Peruzzi D, Mori F, Conforti A, Lazzaro D, De Rinaldis E, Ciliberto G, La Monica N, Aurisicchio L. Clin Cancer Res. 2009 Jun 15;15(12):4104-13. doi: 10.1158/1078-0432.CCR-08-3226. Epub 2009 Jun 9.